Kwality Pharmaceuticals Ltd — Important, 30-05-2026: Company Update

Kwality Pharmaceuticals submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. Practicing company secretaries confirmed the company largely complied with applicable regulations during this period. A past minor deviation was noted for the year ended March 31, 2024, involving a one-day delay in submitting a previous XBRL report. This resulted in a Rs. 2,360 penalty, which has been paid. For the latest review, the company maintained compliance regarding policies, website disclosures, director qualifications, related party transactions, and insider trading rules. This confirms the company's commitment to robust corporate governance.